更新日期:2021年9月28日

1.经济利益

a)获得的研究资金:任何来自Cochrane Collaboration或相关组织(即任何与卫生保健或医学研究相关的组织)的赠款、合同或礼物、委托研究或奖学金?
是的,没有收到Cochrane IPD MA方法团体资助的资金，从Cochrane合作中获取工作，以确定Cochrane评论的有效和无效的干预措施（2018年至今，?? 9600 /年）。其他资助者2021年8月2021日至7月2024年7月（首席调查员）北爱尔兰临床研究回收，恢复力和增长实施计划：3,000,000来自卫生和社会护理部（北爱尔兰）2月2021年至4月2025年4月（共同调查仪）急性呼吸衰竭的粘液吸毒：2x2阶乘，随机，控制，分配隐藏，开放标签，第3阶段，务实，临床，临床和成本效益，与国立卫生研究所（NIHR）健康研究所的1,929,723技术评估（HTA）计划5月20日至5月2021（共同调查员）钻石：糖尿病黄斑水肿和二极管亚阈值微孔激光器（钻石）[延伸]Δω08.88,580来自NIHR HTA计划2018到2020（共同申请人）预期护理计划从Chitin [欧洲联盟] 2018年至2019年（共同申请人）涉及参与开发者的利益相关者的资本攸关方的危险风险T和土耳其国家行动计划的实施，以在叙利亚难民部门的非传染性疾病（NCDS）中，从就业和学习部，全球挑战研究基金[GCRF] 2017年至2025（共同调查员）冠军：童年近视近视的阿托品？2020年（首席调查员）HSC统计和方法研究支持服务?? 150,000来自卫生和社会护理（北爱尔兰）2017年至2020年的研究和发展（共同调查员）清楚：A 2x2阶级随机单盲公开标记试验以确定临床高渗盐水和碳青霉素的成本有效性与通常护理超过12个月的非囊性纤维化支气管扩张，来自NIHR HTA 2017至2020（CO-I）ncedetigator）???杰克试用???一个多网站集群随机试验的交互式薄膜干预，以减少少女怀孕，促进阳性性健康？1,024,556来自NIHR公共卫生研究（PHR）计划2017至2020年（共同调查员）三明治：镇静和断奶儿童：该 SANDWICH trial ??1,773,962 from NIHR HTA 2017 to 2018 (chief investigator) Practical Workshop for Clinical Trials ??23,050 from British Council Newton Fund Workshops 2016 to 2018 (co-investigator) Advance care planning with older patients who have end-stage kidney disease: Feasibility of a deferred entry randomised controlled trial incorporating a mixed methods process evaluation ??145,103 from Dunhill Medical Trust Aug 2016 (principal investigator) Evidence Aid (unrestricted grant) US$65,000 from Lambert Family Foundation Apr 2016 to Aug 2016 (co-investigator) Jack Trial Intervention: refinement of the parental component ??35,742 from Health and Social Care (Northern Ireland) Research and Development Aug 2021 to Jul 2024 (chief investigator) Fund for actioning the Northern Ireland Clinical Research Recovery, Resilience and Growth Implementation Plan: ??3,000,000 from the Department of Health and Social Care (Northern Ireland) Feb 2021 to Apr 2025 (co-investigator) Mucoactive drugs for acute respiratory failure: A 2x2 factorial, randomised, controlled, allocation concealed, open-label, Phase 3, pragmatic, clinical and cost effectiveness trial with internal pilot ??1,929,723 from National Institute of Health Research (NIHR) Health Technology Assessment (HTA) programme May 2020 to May 2021 (co-investigator) DIAMONDS: DIAbetic Macular Oedema aNd Diode Subthreshold micropulse laser (DIAMONDS) [extension] ??88,580 from NIHR HTA programme 2018 to 2020 (co-applicant) Anticipatory care planning intervention for older adults at risk of functional decline ??464,178 from CHITIN [European Union] 2018 to 2019 (co-applicant) Network analysis of stakeholders involved in the development and implementation of a national action plan in Turkey to tackle non-communicable diseases (NCDs) among Syrian refugees ??34,860 from Department for Employment & Learning, Global Challenges Research Fund [GCRF] 2017 to 2025 (co-investigator) CHAMP: Childhood Atropine for Myopia Progression ??800,600 NIHR Efficacy and Mechanism Evaluation (EME) programme 2017 to 2021 (co-investigator) A-Stop: Antifungal stewardship opportunities with rapid tests for fungal infection in critically-ill patients ??1,524,591 from NIHR HTA 2017 to 2020 (chief investigator) HSC Statistical and Methodological Research Support Service ??150,000 from Health and Social Care (Northern Ireland) Research and Development 2017 to 2020 (co-investigator) CLEAR: A 2x2 factorial randomised single blind open labelled trial to determine the clinical and cost effectiveness of hypertonic saline and carbocysteine versus usual care over 12 months in non-cystic fibrosis bronchiectasis ??985,718 from NIHR HTA 2017 to 2020 (co-investigator) ???The JACK Trial??? A multi-site cluster randomised trial of an interactive filmbased intervention to reduce teenage pregnancy and promote positive sexual health ??1,024,556 from NIHR Public Health Research (PHR) programme 2017 to 2020 (co-investigator) SANDWICH: Sedation and weaning in children: the SANDWICH trial ??1,773,962 from NIHR HTA 2017 to 2018 (chief investigator) Practical Workshop for Clinical Trials ??23,050 from British Council Newton Fund Workshops 2016 to 2018 (co-investigator) Advance care planning with older patients who have end-stage kidney disease: Feasibility of a deferred entry randomised controlled trial incorporating a mixed methods process evaluation ??145,103 from Dunhill Medical Trust Apr 2016 to May 2020 (co-investigator) DIAMONDS: DIAbetic Macular Oedema aNd Diode Subthreshold micropulse laser ??893,461 from NIHR HTA Sep 2015 to Aug 2018 (principal investigator) Evidence Aid ???545,000 from C&A Foundation Jul 2015 to Jun 2020 (co-applicant) Irish Primary Care Trials Network (IPC Trials Network) ???2,499,652 from Health Research Board Apr 2015 to Mar 2018 (co-investigator) Is it possible to develop a complex intervention to improve the outcome of critically ill patients with delirium? ??150,350 from Health and Social Care (Northern Ireland) Research and Development Feb 2015 to Dec 2018 (co-applicant) EASI-SWITCH: Early switch to oral antibiotics in patients with low risk neutropenic sepsis ??1,016,416 from NIHR

b)是否已支付咨询费用:任何相关机构的有偿工作、咨询费(现金或实物)?
没有

c)收到酬金:从相关机构一次性支付(现金或实物)?
没有

d)曾在相关机构担任董事、高级人员、合伙人、受托人、雇员或管理职位?
是的,证物援助理事会主席

e)与相关机构持有股份、股票、股票期权、股权(不包括共同基金或个人无法控制股份选择的类似安排)?
没有

f)收到相关机构的个人礼物?
没有

g)在相关机构有未偿还贷款?
没有

h)从相关机构获得版税?
没有

2.你还有其他的利益冲突吗?这些利益冲突可能会合理地表现为与主要利益相关?
没有